Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc2051 MEK1 phosphorylation Ser217 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2052 MEK1 phosphorylation Ser221 human Breast Cancer SK-BR-3 DHA Associated 4.0 (Moderate) 21771724
acc2053 ERK1 phosphorylation Thr202 human Lung Cancer Calu-6 AZD6244 Associated 4.0 (Moderate) 19783898
acc2054 ERK1 phosphorylation Tyr204 human Lung Cancer Calu-6 AZD6244 Associated 4.0 (Moderate) 19783898
acc2055 AKT phosphorylation Ser473 human Lung Cancer HCC2450 AZD6244 Impairing 5.0 (High) 19783898
acc2056 AKT phosphorylation Thr308 human Lung Cancer HCC2450 AZD6244 Impairing 5.0 (High) 19783898
acc2057 ERK2 phosphorylation Thr185 human Lung Cancer Calu-6 AZD6244 Associated 4.0 (Moderate) 19783898
acc2058 ERK2 phosphorylation Tyr187 human Lung Cancer Calu-6 AZD6244 Associated 4.0 (Moderate) 19783898
acc2059 ERK1 phosphorylation Thr202 human Lung Cancer HCC2450 AZD6244 Associated 4.0 (Moderate) 19783898
acc2060 ERK1 phosphorylation Tyr204 human Lung Cancer HCC2450 AZD6244 Associated 4.0 (Moderate) 19783898
acc2061 ERK2 phosphorylation Thr185 human Lung Cancer HCC2450 AZD6244 Associated 4.0 (Moderate) 19783898
acc2062 ERK2 phosphorylation Tyr187 human Lung Cancer HCC2450 AZD6244 Associated 4.0 (Moderate) 19783898
acc2063 AKT phosphorylation Ser473 human Lung Cancer H522 AZD6244 Impairing 5.0 (High) 19783898
acc2064 AKT phosphorylation Thr308 human Lung Cancer H522 AZD6244 Impairing 5.0 (High) 19783898
acc2065 MEK phosphorylation unclear human Breast Cancer MCF7 Silibinin Associated 4.0 (Moderate) 23353996
acc2066 ERK phosphorylation unclear human Breast Cancer MCF7 Silibinin Associated 4.0 (Moderate) 23353996
acc2067 MEK phosphorylation unclear human Thyroid Cancer TPC-1 Silibinin Associated 4.0 (Moderate) 23353996
acc2068 ERK phosphorylation unclear human Thyroid Cancer TPC-1 Silibinin Associated 4.0 (Moderate) 23353996
acc2069 Bcl-2 phosphorylation Ser70 human Leukemia HL-60 Paclitaxel Associated 4.0 (Moderate) 10400418
acc2070 Bcl-2 phosphorylation Ser70 human Leukemia U937 Paclitaxel Associated 4.0 (Moderate) 10400418
acc2071 Bcl-2 phosphorylation Ser70 human Leukemia Jurkat Paclitaxel Associated 4.0 (Moderate) 10400418
acc2072 ERK1 phosphorylation Thr202 human Lung Cancer PC9 Erlotinib Associated 4.0 (Moderate) 23979919
acc2073 ERK1 phosphorylation Tyr204 human Lung Cancer PC9 Erlotinib Associated 4.0 (Moderate) 23979919
acc2074 ERK2 phosphorylation Thr185 human Lung Cancer PC9 Erlotinib Associated 4.0 (Moderate) 23979919
acc2075 ERK2 phosphorylation Tyr187 human Lung Cancer PC9 Erlotinib Associated 4.0 (Moderate) 23979919
acc2076 ERK1 phosphorylation Thr202 human Lung Cancer HCC827 Erlotinib Associated 4.0 (Moderate) 23979919
acc2077 ERK1 phosphorylation Tyr204 human Lung Cancer HCC827 Erlotinib Associated 4.0 (Moderate) 23979919
acc2078 ERK2 phosphorylation Thr185 human Lung Cancer HCC827 Erlotinib Associated 4.0 (Moderate) 23979919
acc2079 ERK2 phosphorylation Tyr187 human Lung Cancer HCC827 Erlotinib Associated 4.0 (Moderate) 23979919
acc2080 FAK phosphorylation Tyr human Breast Cancer MDA-MB-231 Met-F-AEA Associated 4.0 (Moderate) 16343481
acc2081 Src phosphorylation Tyr human Breast Cancer MDA-MB-231 Met-F-AEA Associated 4.0 (Moderate) 16343481
acc2082 FAK phosphorylation Tyr mouse Breast Cancer TSA-E1 Met-F-AEA Associated 4.0 (Moderate) 16343481
acc2083 Src phosphorylation Tyr mouse Breast Cancer TSA-E1 Met-F-AEA Associated 4.0 (Moderate) 16343481
acc2084 ERK1 phosphorylation Thr202 human Melanoma Sbcl2 Azacitidine Associated 4.0 (Moderate) 34866327
acc2085 ERK1 phosphorylation Tyr204 human Melanoma Sbcl2 Azacitidine Associated 4.0 (Moderate) 34866327
acc2086 ERK2 phosphorylation Thr185 human Melanoma Sbcl2 Azacitidine + Trametinib Associated 4.0 (Moderate) 34866327
acc2087 ERK2 phosphorylation Tyr187 human Melanoma Sbcl2 Azacitidine + Trametinib Associated 4.0 (Moderate) 34866327
acc2088 ERK2 phosphorylation Thr185 human Melanoma Sbcl2 Azacitidine Associated 4.0 (Moderate) 34866327
acc2089 ERK2 phosphorylation Tyr187 human Melanoma Sbcl2 Azacitidine Associated 4.0 (Moderate) 34866327
acc2090 ERK1 phosphorylation Thr202 human Melanoma Sbcl2 Trametinib Associated 4.0 (Moderate) 34866327
acc2091 ERK1 phosphorylation Tyr204 human Melanoma Sbcl2 Trametinib Associated 4.0 (Moderate) 34866327
acc2092 ERK2 phosphorylation Thr185 human Melanoma Sbcl2 Trametinib Associated 4.0 (Moderate) 34866327
acc2093 ERK2 phosphorylation Tyr187 human Melanoma Sbcl2 Trametinib Associated 4.0 (Moderate) 34866327
acc2094 ERK1 phosphorylation Thr202 human Melanoma Sbcl2 Azacitidine + Trametinib Associated 4.0 (Moderate) 34866327
acc2095 ERK1 phosphorylation Tyr204 human Melanoma Sbcl2 Azacitidine + Trametinib Associated 4.0 (Moderate) 34866327
acc2096 MMP-9 phosphorylation unclear human Breast Cancer MCF7 SFN Associated 4.0 (Moderate) 35988280
acc2097 MMP-9 phosphorylation unclear human Breast Cancer MDA-MB-231 SFN Associated 4.0 (Moderate) 35988280
acc2098 eIF4E phosphorylation Ser209 human Leukemia MV4-11 Merestinib Associated 4.0 (Moderate) 27307295
acc2099 eIF4E phosphorylation Ser209 human Leukemia MM6 Merestinib Associated 4.0 (Moderate) 27307295
acc2100 KNL1 phosphorylation Thr875 human Breast Cancer MDA-MB-231 Paclitaxel Impairing 5.0 (High) 31575759